Associate Professor Daniel Pellicci completed his PhD in 2013 at the University of Melbourne, prior to heading the Cellular Immunology Group at the Murdoch Children’s Research Institute in 2018. His research is focused on the development, function and role of human unconventional T cells in infectious diseases. His lab employs high-dimensional spectral flow cytometry and transcriptomic analysis to provide new insight into how unconventional T cells mediate protective human immunity. His work on understanding the development of human unconventional T cells has led new opportunities to develop these cells as an ‘off the shelf’ therapy to treat human cancer and infection. Daniel’s research is supported by a Sylvia & Charles Viertel Fellowship and The National Health and Medical Research Council.